|
|
Volumn 57, Issue 7, 2013, Pages 2967-2971
|
|
Pharmacokinetics of zanamivir following intravenous administration to subjects with and without renal impairment
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ZANAMIVIR;
ABDOMINAL PAIN;
ADULT;
AGED;
AREA UNDER THE CURVE;
ARTICLE;
ASTHENIA;
BLOOD SAMPLING;
CLINICAL ARTICLE;
CONTROLLED STUDY;
COUGHING;
CREATININE BLOOD LEVEL;
CREATININE CLEARANCE;
DIAGNOSTIC PROCEDURE;
DIARRHEA;
DISEASE SEVERITY;
DIZZINESS;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG DISTRIBUTION;
DRUG ELIMINATION;
DRUG ERUPTION;
DRUG HALF LIFE;
DRUG SAFETY;
DRUG SCREENING;
ELECTROCARDIOGRAM;
FAINTNESS;
FEMALE;
HEADACHE;
HEART INFARCTION;
HEART PALPITATION;
HUMAN;
KIDNEY CLEARANCE;
KIDNEY DYSFUNCTION;
KIDNEY FUNCTION;
MALE;
MAXIMUM PLASMA CONCENTRATION;
MYALGIA;
NOSE OBSTRUCTION;
OPEN STUDY;
PRIORITY JOURNAL;
SIDE EFFECT;
SINGLE DRUG DOSE;
THORAX PAIN;
TIME TO MAXIMUM PLASMA CONCENTRATION;
UPPER RESPIRATORY TRACT INFECTION;
URINALYSIS;
VITAL SIGN;
ADOLESCENT;
ADULT;
AGED;
ANTIVIRAL AGENTS;
CREATININE;
FEMALE;
HUMANS;
INFLUENZA, HUMAN;
INFUSIONS, INTRAVENOUS;
MALE;
METABOLIC CLEARANCE RATE;
MIDDLE AGED;
RENAL INSUFFICIENCY;
YOUNG ADULT;
ZANAMIVIR;
|
|
EID: 84879029179
PISSN: 00664804
EISSN: 10986596
Source Type: Journal
DOI: 10.1128/AAC.02330-12 Document Type: Article |
|
Times cited : (12)
|
|
References (6)
|
